| |
|
|
|
Xtalks, Online
2025-05-22
For biotechnology companies and startups, selecting the right clinical trial endpoints is essential for regulatory success, investor confidence and efficient trial execution.
This webinar will explore best practices for endpoint strategy, ensuring alignment with scientific and regulatory expectations while balancing feasibility and cost. The expert panel will discuss key considerations for endpoint selection, the role of operational excellence in trial execution and strategies for mitigating risks through project assurance.
Attendees will gain insights into optimizing trial design, selecting the right CRO partners and leveraging innovative technologies to generate high-quality, reliable clinical evidence. Through real-world case studies and proven methodologies, this session will equip biotechs with the information needed to enhance trial efficiency, minimize delays and accelerate their path to approval.
Register for this webinar today to help biotechs navigate endpoint challenges in clinical trials and accelerate their path to drug approval.
Keywords: Clinical Trials, Biotechnology, Clinical Research, Biotech, CRO, Clinical Operations, Clinical Trial Design, Clinical Study Design, Clinical Endpoints, Endpoints, Clinical Trial Endpoints
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Dr. Todd Rudo, MD EVP, Chief Medical Officer, Clario
Chris Clendening, SVP, Biotechnology Operations, Clario
John Ohrn, SVP, Global Sales and Customer Success, Clario
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-05-22
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|